That's correct.
We've kind of figured this out over the past several years of operating. We have a search team of very experienced scientists with industry focus who go to our partner institutions across Canada. All of the health research institutions are part of our network in Canada. They travel to Memorial University, Dalhousie, and all across the country. They look at projects, speak to investigators, and try to figure out whether there's a commercially promising piece of research that they're working on, and develop a project plan. Once we have a project plan, we pull in, and they all take a look at the plans and figure out which projects they wish to fund.
Right from the very beginning, we have external validation in terms of independent review of the science, and also some indication that there's some market pull, that there's some real interest in this technology as an investable and developable drug.